MedTrace Logo

A Mobile Brain/Body Imaging Platform for the Assessment and Optimization of Post-stroke Overground Robotic Gait Treatments

NCT07510633 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-04-03

No results posted yet for this study

Summary

The study aims to identify neural biomarkers that can be used to monitor the recovery of locomotion and movement of post-stroke patients, both in natural settings and with enriched treatment using robotic device. These biomarkers could potentially be utilized in clinical practice to improve recovery outcomes. Additionally, the study seeks to investigate whether it is feasible to use these biomarkers to predict the extent of recovery that patients may achieve.

Conditions

Interventions

DEVICE

overground wearable robotic device

To provide a complete overview of the complex system patient-technology, motor and cognitive evaluations, commonly used in daily clinical practice, will be performed at pre-treatment time (T0), after 12 sessions of treatment (T1) and one month follow-up time (T2). The first (E1) and the last session (E12) of treatment will be instrumented with EEG, EMG and GRF which will collect data.

Sponsors & Collaborators

  • Dr. Franco Molteni

    lead OTHER

Principal Investigators

  • Franco Molteni, MD · Villa Beretta Rehabilitation Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-06
Primary Completion
2027-05-31
Completion
2027-05-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07510633 on ClinicalTrials.gov